Figures
Abstract
Prior research has shown suboptimal health and longevity among Native Americans in the Four Corners region of the United States, which encompasses Arizona, New Mexico, Colorado, and Utah. Our study (1) investigates how life expectancy trends and disparities changed among non-Hispanic Native Americans and Whites in the Four Corners States (FCS) during the COVID-19 pandemic and (2) examines the extent to which longevity changes are directly attributable to COVID-19, relative to other causes of death. Data sources include mortality data from the National Center for Health Statistics and population data from the U.S. Census Bureau. Life expectancy at birth for four race-sex groups in the FCS (Native American and White females and males) was calculated using abridged life table procedures, both pre-pandemic (2018−19) and peak pandemic (2020−22). Gaps in life expectancy between groups (and changes within groups) were decomposed into multiple causes of death to determine which causes contributed most to life expectancy gaps and changes across time periods. Life expectancy declined in the FCS over the study period; whereas Native American male and female longevity decreased by 7.33 years and 6.76 years, respectively, White male and female longevity decreased by 2.11 years and 1.72 years, respectively. Results indicate that the peak pandemic life expectancy gap between Native Americans and Whites widened by over 5 years, regardless of sex. Although COVID-19 was the single largest contributor to longevity changes within and between groups, causes of death related to drug and alcohol use also made notable contributions, especially among Native Americans. Restoring longevity to pre-pandemic levels in the FCS will require improved management of COVID-19 as well as heightened attention to the deleterious role of substance use in indigenous communities.
Citation: Lenarz AM, Park H, Roberts MT, Pan A, Hofmann ET, Reither EN (2026) The impact of COVID-19 on longevity trends and disparities among Native Americans and Whites in the Four Corners States. PLoS One 21(5): e0347924. https://doi.org/10.1371/journal.pone.0347924
Editor: Kala M. Mehta, UCSF: University of California San Francisco, UNITED STATES OF AMERICA
Received: August 26, 2025; Accepted: April 9, 2026; Published: May 18, 2026
Copyright: © 2026 Lenarz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Due to a data-use agreement with the National Center for Health Statistics (NCHS), these data cannot be shared publicly. Researchers may request access to the restricted-use data by submitting a research proposal to the National Center for Health Statistics at nvssrestricteddata@cdc.gov.
Funding: This research was supported by the Utah Agricultural Experiment Station (approved as paper number 9995) and the Utah State University Libraries Open Access Funding Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
While no race or ethnic group in the United States (US) was unaffected by the COVID-19 pandemic, Native Americans were disproportionately impacted. According to the US Census Bureau, American Indians and Alaskan Natives (AIAN) experienced a mortality increase of 36.7% in 2020, the largest increase in any US racial/ethnic group [1]. Indigenous people in the Four Corners states (FCS), which encompasses Arizona, New Mexico, Colorado, and Utah, were especially vulnerable to the adverse impacts of COVID-19, including severe illness and premature mortality [2,3]. To illustrate, relative to non-Hispanic Whites, COVID-19 standardized mortality ratios among Native Americans in Arizona (8.3) and New Mexico (9.9) were much higher than most other states, such as California (1.7), Texas (0.9), Oklahoma (2.3), Minnesota (2.7), and Michigan (1.5) [2].
Prior research in the FCS has established a persistent life expectancy disadvantage among the non-Hispanic AIAN population. For example, a pre-pandemic study in the FCS found notable differences in life expectancy between non-Hispanic AIAN and White populations, both for males (4.92-year gap) and females (2.06-year gap) [4]. A more recent study examining US AIAN longevity during the pandemic found that, relative to 2019, life expectancy decreased by 4.5 years in 2020 and 6.4 years in 2021 [5]. Moreover, US AIAN life expectancy in 2022 was still four years lower than in 2019 [6]. Research suggests that an increase in non-COVID deaths such as drug overdose, chronic liver disease, diabetes, and heart disease contributed to the stagnation of US AIAN life expectancy in 2022 [6]. To date, however, no study has examined how COVID-19 impacted longevity trends and disparities among Native Americans and Whites in the FCS, relative to other causes of death such as drug and alcohol use. Consequently, the overarching objective of this study is to investigate how the COVID-19 pandemic impacted longevity trends and disparities among indigenous people in the FCS.
FCS Tribes
According to the 2010 Census, over 500,000 individuals in the FCS identified as single race AIAN [7]. The FCS has numerous tribal lands and reservations including Navajo Nation, which is the largest reservation in the United States [8]. New Mexico has 23 federally-recognized tribes; Arizona has 22, Utah has eight, and Colorado has two [9–12]. In addition to Navajo, the FCS is home to Apache, Goshute, Hopi, Hualapai, Paiute, Pascua Yaqui, Pueblo, Quechua, Shoshone, Tohono O’odham Ute, Yavapai, and Zuni tribes, among others [9–12].
COVID-19 risk factors
Relative to non-Hispanic Whites, Native Americans have higher rates of chronic disease and poverty with lower rates of health insurance coverage and health literacy, which increases their risk for severe COVID-19 and limits their ability to prevent transmission and access medical care [2,3,13–15]. Indigenous people also have higher rates of asthma, COPD, heart and kidney disease, obesity, and diabetes [2,16]. Relative to other racial/ethnic groups, Native Americans are more likely to live below the poverty line, work in a frontline job (i.e., non-remote jobs that require frequent proximity to other people), or be unemployed [2,3,15]. AIAN individuals have the lowest rates of health insurance coverage among all racial/ethnic groups in the US [2,3,13]. For example, in 2021, the uninsured rate for non-Hispanic AIAN was 18.8%, compared to just 5.7% for non-Hispanic Whites [13]. Furthermore, private health insurance coverage was significantly lower among non-Hispanic AIAN individuals (43.1%) than among non-Hispanic Whites (74.2%) [13]. Additionally, historical trauma and discrimination have led to mistrust of the health care system and COVID-19 vaccination hesitancy among indigenous groups, creating additional barriers to care and prevention [17,18]. All these factors have likely contributed to a disproportionate number of COVID-19 cases and deaths in AIAN communities.
Prior research has shown that residents of Navajo Nation experience some of the most acute risks to health and longevity in the US, even relative to other indigenous groups [3,19–21]. Navajo Nation has very high percentages of residents in poverty (40.2%), adults without a high school diploma (26.9%), overcrowded housing conditions (17.4%), households without a vehicle (14.4%), and households with incomplete plumbing (18%) [2,3,21]. Additionally, a relatively large number of Pueblo and Navajo households do not speak English, which can make it difficult to secure resources such as employment and adequate healthcare [21]. Moreover, many reservations in the FCS are highly rural and lack advanced medical facilities capable of treating severe cases of COVID-19 [19,20].
The two primary aims of this study are to (1) investigate how the COVID-19 pandemic impacted life expectancy trends among non-Hispanic AIAN and Whites in the FCS, and (2) understand the extent to which changes in longevity and longevity disparities in the FCS are directly attributable to COVID-19 versus other causes of death. This study will decompose life expectancy changes within (and gaps between) AIAN and White populations in the FCS, allowing us to determine which causes of death contributed most to these changes and gaps during the COVID-19 pandemic. As noted, while some prior studies have examined how COVID-19 impacted longevity among Native Americans, none have employed decomposition methods to disentangle COVID-19 from other causes of death among AIAN and Whites in the FCS region.
Methods
Data
To assess longevity changes in the FCS over the period 2018–2022, single-race population data from the US Census Bureau for Arizona, Colorado, New Mexico, and Utah were utilized [22]. In addition, restricted-use mortality data (2018–2022) sourced from the US National Center for Health Statistics (NCHS) were included in our investigation [23].
Measures
Measures in our data include sex, age, race/ethnicity, and cause-of-death. Age at death was organized into 19 categories (less than 1 year old, 1–4 years old, a series of five-year age groups from 5–9 to 80–84, and 85 and above). The measurement for race was based on six revised single-race categories, which includes White, Black or African American, Asian, AIAN, Native Hawaiian or Other Pacific Islander, and more than one race [24]. Analyses included single race non-Hispanic AIAN (hereafter NH AIAN) and non-Hispanic White (hereafter NH White) populations in the FCS [25]. A small number of individuals identified as belonging to “multiple races” was excluded from the analyses. The analyses also excluded the Hispanic population because this group often exhibits socioeconomic, cultural, behavioral, and health profiles that differ from non-Hispanic populations [26].
The 10th revision of the International Classification of Diseases (ICD-10) was utilized to identify the 39 leading causes of death in the US [27]. These categories are mutually exclusive and exhaustive, encompassing a wide range of medical conditions and external causes, including specific types of heart disease and cancer, chronic lower respiratory diseases, cerebrovascular disease, Alzheimer’s disease, diabetes, influenza and pneumonia, and nephritis, among others [27]. Analyses also incorporated alcohol-related causes of death as defined by the Alcohol-Related Disease Impact (ARDI) classification scheme, by isolating different ARDIs and then subtracting them from the 39 leading causes of death [28]. ARDIs were classified into chronic or acute conditions that are either 100% attributable to alcohol (e.g., acute alcohol poisoning) or have alcohol-attributable fractions (AAF) that are directly related to alcohol use (e.g., fatal motor vehicle crashes involving alcohol use) [28]. A detailed description and the complete list of ICD-10 codes used in the ARDI application are available elsewhere [28]. S1 Table provides a list of ICD-10 codes for the 39 causes of death and ARDI.
Analysis
The first step was to construct a series of sex-specific period life tables for NH AIAN and NH White populations, spanning the period 2018–2022. Using death records from the NCHS and single-race population data from the U.S. Census Bureau, sex- and age-specific death rates (ASDR) were calculated for both populations. Sex-specific ASDR were used to estimate life expectancies at birth for NH AIAN and NH White populations in the FCS across the study period, following standard procedures for creating abridged life tables [29].
The second step of the analysis involved decomposing life expectancy gaps into age- and cause-of-death components, using the approach proposed by Arriaga [29,30]. Data for decomposition analyses were combined into two- or three-year aggregates of deaths and population data (i.e., pre-pandemic, 2018−19 and peak pandemic, 2020−22), similar to approaches used in previous research [4]. The total life expectancy gap was decomposed into years according to the relative contributions of each age group, followed by the specific causes of death within each age group. Age- and cause-specific decompositions were applied to the life expectancy differences for males and females 1) between NH AIAN and NH White populations at two different time points (i.e., 2018−19 and 2020−22) and 2) within these two populations before and after COVID-19.
The final step was to identify causes of death that were particularly relevant to our selected populations in the FCS. Among the 39 leading causes of death and ARDI we examined, select causes were presented in our final report if they contributed at least 0.20 years to 1) the life expectancy gap between NH AIAN and NH White populations for either males or females in at least one time period, or 2) changes in life expectancy for at least one race/sex group that occurred after the onset of COVID-19. For between-group differences, causes of death that met these criteria included COVID-19, diabetes mellitus, heart disease, malignant neoplasms (i.e., various cancers), symptoms and abnormal clinical/laboratory findings not elsewhere classified (excluding sudden infant death syndrome), influenza and pneumonia, nephritis/nephrotic syndrome/nephrosis, Alzheimer’s disease, chronic lower respiratory diseases, other external causes and unspecified accidents, alcohol abuse and poisoning, alcoholic liver disease, alcohol-related liver cirrhosis, alcohol-related vehicle crashes, alcohol-related homicide, non-alcohol poisoning, and alcohol-related suicide. For within-group changes, the only causes of death that met our inclusion criteria were COVID-19, heart disease, alcoholic liver disease, alcohol-related liver cirrhosis, and non-alcohol poisoning. In both analyses, we included a residual category to account for all other causes of death that did not meet our inclusion criteria.
In line with our research objectives, the results were presented in three parts: first, an overview of life expectancy trends; second, a detailed analysis of the gaps in life expectancy between race/sex groups; and third, an examination of life expectancy changes within each race/sex group. Analyses were conducted using SAS version 9.4 (Cary, NC), R (R Core Team), and MS Excel [30]. Restricted data for the analyses were obtained with permission from the NCHS (Contract number: DVS2024−0259). Our university’s institutional review board considered this study exempt from review (protocol number: 14619).
Results
Fig 1 illustrates FCS trends in life expectancy at birth by sex and race/ethnicity from 2018 to 2022. In 2018, life expectancy was 82.56 years for NH White females, 78.06 years for NH White males, 77.70 years for NH AIAN females, and 68.41 years for NH AIAN males. These life expectancies were relatively stable in 2019 but dropped substantially in the first year of the COVID-19 pandemic (i.e., 2020), especially among NH AIAN people. In 2021, longevity reached its lowest level among all four groups, falling to 80.19 years for NH White females, 75.23 years for NH-White males, 69.18 years for NH AIAN females, and 59.62 for NH AIAN males. In 2022, life expectancy rebounded for each group but did not return to pre-pandemic levels. While the pandemic reduced life expectancy for both NH AIAN and NH White populations, it had an acute impact on NH AIAN males and females, who experienced sharp declines in longevity.
Abbreviations. NH (Non-Hispanic); AIAN (American Indian or Alaska Native).
Table 1 summarizes the contribution of select causes of death to racial/ethnic life expectancy gaps, expressed as sex-specific differences between NH White and NH AIAN populations in each period of observation. During the COVID-19 pandemic, racial/ethnic longevity gaps grew by about five years, regardless of sex, increasing from 9.75 years in 2018−19 to 14.97 years in 2020−22 among males and from 5.20 years in 2018−19 to 10.24 years in 2020−22 among females. Before the pandemic, the 9.75-year life expectancy gap between NH AIAN and NH White males was largely attributable to alcoholic liver disease (1.25 years), alcohol-related motor vehicle traffic crashes (1.14 years), alcohol abuse and poisoning (1.13 years), all other external causes or unspecified accidents (0.99 years), and diabetes mellitus (0.89 years). During the pandemic, COVID-19 (3.20 years) and non-alcohol poisoning (0.85 years) emerged as key contributors to the 14.97-year gap among males, along with the aforementioned causes of death. Among females, the 5.20-year life expectancy gap prior to the pandemic was mainly attributable to alcoholic liver disease (1.18 years), diabetes mellitus (0.92 years), alcohol-related liver cirrhosis (0.57 years), alcohol-related motor vehicle traffic crashes (0.54 years), and alcohol abuse and poisoning (0.45 years). Similar to males, COVID-19 (3.15 years) and non-alcohol poisoning (0.38 years) emerged as important contributors to the 10.24-year longevity gap among females during the pandemic, in addition to the causes of death previously noted. Somewhat counterintuitively, several causes of death consistently favored NH AIAN over NH Whites, meaning they were less prevalent among AIAN, such as Alzheimer’s disease and chronic lower respiratory diseases among both males and females, and diseases of heart and malignant neoplasms among females.
The age distribution of the top six contributors to racial/ethnic life expectancy gaps in 2020−22 is depicted in Fig 2 for males and Fig 3 for females. Among both males and females, these causes of death made only modest contributions to longevity gaps prior to the age of 15. In their late teens and 20s, fatalities due to alcohol-related motor vehicle crashes increased substantially for NH AIAN, particularly among males. Among both males (Fig 2) and females (Fig 3) in their late 20s through their early 50s, mortality from alcohol abuse and poisoning and especially from alcoholic liver disease made large contributions to racial/ethnic longevity gaps. To illustrate, alcoholic liver disease contributed over 0.30 years to the racial/ethnic longevity gap at age 35−39 alone, regardless of sex. While COVID-19 made the largest contributions to life expectancy gaps, it did so at relatively younger ages for males, who experienced maximum effects in their 40s, than for females, who experienced maximum effects in their 60s. Other notable contributors among males were non-alcoholic isoning (e.g., accidental drug overdose), which peaked in their late 30s, and other external causes or unspecified accidents, which peaked during their early 40s. Among females, other important contributors included alcohol-related unspecified liver diseases, which had the largest impact between ages 30 and 54, and diabetes mellitus, which gradually increased in magnitude from mid-to-late life.
The longevity gap of 14.97 years in 2020−22 was decomposed into numerous causes of death at specific ages. The causes depicted here are the leading six contributors to this life expectancy gap. Abbreviations. NH (Non-Hispanic); AIAN (American Indian or Alaska Native).
The longevity gap of 10.24 years in 2020−22 was decomposed into numerous causes of death at specific ages. The causes depicted here are the leading six contributors to this life expectancy gap. Abbreviations. NH (Non-Hispanic); AIAN (American Indian or Alaska Native).
Table 2 presents the contribution of select causes of death to life expectancy changes within each sex and racial/ethnic group, expressed as years lost (negative change) from 2018−19–2020−22. During the pandemic, life expectancy at birth declined by 7.33 years for NH AIAN males and 6.76 years for AIAN females; by comparison, life expectancy declined by 2.11 and 1.72 years among NH White males and females, respectively. COVID-19 was the most substantial contributor to these declines in life expectancy, accounting for at least 50% of longevity change in each race/sex group. Among NH AIAN males, other important contributors to the 7.33-year loss in life expectancy included non-alcohol (i.e., other drug) poisoning (−0.81 years), alcoholic liver disease (−0.57 years), and alcohol abuse and poisoning (−0.29 years). Among NH AIAN females, alcoholic liver disease (−0.49 years), non-alcohol poisoning (−0.35 years), and alcohol-related liver cirrhosis (−0.33) made notable contributions to the 6.76-year decline in longevity. For both NH White males and females, diseases of the heart and non-alcohol poisoning were important contributors to the roughly two-year loss of life expectancy experienced by each group.
Discussion
Using restricted-use NCHS data from 2018−2022, our study investigated trends and racial disparities in life expectancy in the FCS during the COVID-19 pandemic. We assessed the relative contributions of COVID-19 and other causes of death to life expectancy decline within racial groups and to disparities between racial groups. Our results were consistent with findings from previous research indicating high mortality rates and declines in life expectancy due to COVID-19 and alcohol-related causes of deaths among indigenous people in the FCS [1–3,5,6,31].
The COVID-19 pandemic had a detrimental impact on life expectancy and exacerbated pre-existing longevity disparities between NH AIAN and NH Whites in the FCS. Among NH AIAN in the FCS, longevity decreased by 7.33 years for males and 6.76 years for females between 2018−19 and 2020−22. Goldman and Andrasfay found an average life expectancy decrease of 6.4 years for the overall US population of NH AIAN between 2019 and 2021 [5]. Using that same metric (see our 2019 and 2021 estimates in Fig 1), our findings showed an even greater reduction in longevity (>8 years) among NH AIAN males and females in the FCS. These results support prior studies which argue that tribes within the FCS were especially vulnerable to the COVID-19 pandemic due to various structural inequalities [2,3,20,21].
Alcohol use disorder, which is associated with both acute and chronic causes of death and has higher prevalence among NH AIAN than NH Whites [28,32–35]. Alcohol use disorder contributes to a stark mortality gap, with death rates from excessive alcohol use reaching 145.3 per 100,000 in the AIAN population, compared to 63.8 in the NH White population [31]. Our results indicate that alcohol-related deaths contributed substantially to the racial gap in life expectancy in the FCS. Furthermore, our analysis advances this literature by quantifying the age-specific contributions of alcohol-related causes of death to longevity disparities between NH AIAN and NH White populations in the FCS.
Relative to other causes of death, COVID-19 was the single largest contributor to the reduction in life expectancy for both NH AIAN and NH Whites in the FCS. Longevity among NH AIAN males and females also decreased during the pandemic due to heart disease, non-alcohol poisoning, alcoholic liver disease, and alcohol abuse and poisoning. This suggests that alcohol and other substances may have been used as coping mechanisms during this time of distress and social isolation among NH AIAN in the FCS. Among NH White males and females, life expectancy declined during the pandemic due to some causes of death other than COVID-19 but to a much lesser degree.
With respect to the widening longevity gap between NH AIAN and NH Whites in the FCS, COVID-19 was the single largest contributor (>3 years for both males and females) during the pandemic. In addition, alcoholic and alcohol-related liver diseases, alcohol abuse and poisoning, non-alcohol poisoning, and alcohol-related suicide all made larger contributions to longevity gaps between NH AIAN and NH Whites during the pandemic than in the previous period (i.e., 2018−19), regardless of sex. Other important contributors to life expectancy disparities such as alcohol-related homicide, alcohol-related vehicle crashes, and diabetes either declined slightly or differed between sexes in their impact during the pandemic but continued to make notable contributions. During the pandemic, substance use, suicidality, and mental illness symptoms increased due to stress, isolation, and trauma—especially among AIAN individuals [36–38]. The negative mental health effects of trauma and loss of cultural and community roots historically experienced by AIAN individuals created vulnerability to the adverse effects of the COVID-19 pandemic, unfortunately including sharp increases in mortality [38–40].
Public health implications
Despite inherent difficulties in overcoming the social and economic disadvantages faced by AIAN that contribute to reduced health and longevity, research suggests that they can be addressed with targeted interventions. Structural inequalities such as poverty, food insecurity, incomplete plumbing, overcrowded housing, inadequate access to transportation, and barriers to healthcare services (e.g., lower rates of health insurance coverage) all contribute to insufficient preventive care and increased risk for morbidity, including severe cases of COVID-19 [2,3,13,14,16–21,41–43]. Discrimination against indigenous groups and historical events have contributed to mistrust of the health care system and vaccination hesitancy, also placing AIAN individuals at heightened risk for COVID-19 and its complications [17,18]. Cultural sensitivity and improved representation of indigenous people among public health and medical professionals may help overcome distrust and other healthcare barriers, contributing to improved vaccine uptake and better general preventive care.
Drug and alcohol use often coincide with mental illness and trauma [44,45]. Native American adolescents and young adults have high rates of mental illness, particularly as they relate to substance and alcohol use disorders [46,47]. Mental illness, substance use disorders, and alcohol and drug use are all risk factors for accidental deaths (e.g., fatal motor vehicle accidents), homicide, and suicide [48,49]. The mortality age patterns we found suggest that early interventions to support mental health and prevent alcohol use are crucial within the AIAN population. Culturally informed and community-based interventions are crucial to reducing deaths associated with underlying mental illness such as alcohol and drug overdose, suicide, and homicide among indigenous populations [40,50].
Strengths and limitations
Restricted-use NCHS data helped us achieve accurate numerator counts, especially in rural counties where public mortality data tend to be censored due to low numbers. In addition, our use of decomposition methods enabled us to assess how numerous causes of death at different ages contributed to life expectancy changes and gaps during the height of the COVID-19 pandemic. Although we explained most of the life expectancy gaps and changes over this period of observation, 15–30% of these gaps and changes were unaccounted for by the causes of death examined in our analyses. While restricted-use NCHS data provide the most accurate mortality estimates available, they are not linked to economic data or health history information, limiting the ability of analysts to account for these factors. Finally, racial misclassification on death records is common among NH AIAN individuals in the US and may be more prevalent in urban areas and populations with a low percentage of NH AIAN people [51,52]. However, prior research has shown that the Southwest region, which encompasses the FCS, has a much lower misclassification rate than other US regions [51]. Therefore, because our study population lies within the Southwest and is predominantly rural with large NH AIAN majorities in some areas, we expect misclassification bias to be minimal.
Conclusions
In the FCS, life expectancy declined among both NH AIAN and NH Whites during the COVID-19 pandemic. However, indigenous people were disproportionately impacted by the pandemic, which exacerbated pre-existing longevity disparities. Current public health initiatives and policies are not adequately addressing health and mortality disparities among indigenous groups in the US [41]. To improve NH AIAN well-being and prevent losses to future health crises such as infectious disease outbreaks in the FCS, access to preventive care and public health responses need to be improved in this population. Creative and concerted efforts from all parties can bolster extant programs and catalyze the development of novel interventions that are designed to address difficult health challenges faced by NH AIAN in the FCS, helping to alleviate suffering and premature mortality in this group of Native Americans.
Supporting information
S1 Table. List of ICD10 codes by the 39 leading causes of death and alcohol-related disease impact classification. Sources: CDC, National Center for Health Statistics. Instruction Manual ICD-10 Cause-of-Death Lists for Tabulating Mortality Statistics. 2009; CDC. Alcohol Related Disease Impact (ARDI) Application Website. 2024. Available: www.cdc.gov/ARDI.
https://doi.org/10.1371/journal.pone.0347924.s001
(PDF)
References
- 1.
Sabo S, Johnson S. Males and the Hispanic, American Indian and Alaska Native populations experienced disproportionate increases in deaths during pandemic. Census.gov. https://www.census.gov/library/stories/2023/06/covid-19-impacts-on-mortality-by-race-ethnicity-and-sex.html 2023. 2024 November 7.
- 2. Leggat-Barr K, Uchikoshi F, Goldman N. COVID-19 risk factors and mortality among Native Americans. DemRes. 2021;45:1185–218.
- 3. Hathaway ED. American Indian and Alaska Native People: Social Vulnerability and COVID-19. J Rural Health. 2021;37(1):256–9. pmid:32744339
- 4. Omisakin OA, Park H, Roberts MT, Reither EN. Contributors to reduced life expectancy among Native Americans in the Four Corners States. PLoS One. 2021;16(8):e0256307. pmid:34403430
- 5. Goldman N, Andrasfay T. Life expectancy loss among Native Americans during the COVID-19 pandemic. Demogr Res. 2022;47:233–46. pmid:36506651
- 6. Goldman N, Park S, Hiram B-S B. Life expectancy among Native Americans during the COVID-19 pandemic: estimates, uncertainty, and obstacles. Am J Epidemiol. 2024;193:846–52.
- 7.
Norris T, Vines PL, Hoeffel EM. The American Indian and Alaska Native Population: 2010. 2012.
- 8.
Indian Health Services. Navajo Nation. Navajo Area. https://www.ihs.gov/navajo/navajonation/ 2024 October 24.
- 9.
Arizona Department of Education. 22 Federally Recognized Tribes in Arizona. Arizona Department of Education. https://www.azed.gov/oie/22-federally-recognized-tribes-arizona 2025 June 25.
- 10.
Angell S. Celebrating Utah’s Native Peoples and History. Utah Valley University. https://www.uvu.edu/news/2023/11/2023_11_02_native_american_initiative.html 2023. 2025 June 25.
- 11.
Meisenhemier A. Guides: Native American and Indigenous Studies: Tribes in Colorado. Regis University. https://libguides.regis.edu/c.php?g=1269914&p=10618144 2025 June 25.
- 12.
Native American Election Information Program. 23 NM Federally Recognized Tribes in NM Counties. New Mexico Secretary of State. https://www.sos.nm.gov/voting-and-elections/native-american-election-information-program/23-nm-federally-recognized-tribes-in-nm-counties/ 2025 June 25.
- 13.
Branch B, Conway D. Health Insurance Coverage by Race and Hispanic Origin: 2021. 2021.
- 14. Adamsen C, Schroeder S, LeMire S, Carter P. Education, Income, and Employment and Prevalence of Chronic Disease Among American Indian/Alaska Native Elders. Prev Chronic Dis. 2018;15:E37. pmid:29565785
- 15.
Labor force characteristics by race and ethnicity, 2021. 2023. https://www.bls.gov/opub/reports/race-and-ethnicity/2021/
- 16. Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, et al. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 2021;19(1):212. pmid:34446016
- 17. Gonzalez VM, Stewart TJ. COVID-19 vaccine hesitancy among American Indian and Alaska native college students: the roles of discrimination, historical trauma, and healthcare system distrust. J Behav Med. 2024;47(1):123–34. pmid:37634151
- 18. Stewart TJ, Gonzalez VM. Associations of historical trauma and racism with health care system distrust and mental health help-seeking propensity among American Indian and Alaska Native college students. Cultur Divers Ethnic Minor Psychol. 2023;29(3):348–57. pmid:37067492
- 19. Denetclaw WF, Otto ZK, Christie S, Allen E, Cruz M, Potter KA, et al. Diné Navajo Resilience to the COVID-19 pandemic. PLoS One. 2022;17(8):e0272089. pmid:35925907
- 20. Kakol M, Upson D, Sood A. Susceptibility of Southwestern American Indian Tribes to Coronavirus Disease 2019 (COVID-19). J Rural Health. 2021;37:197–9.
- 21. Rodriguez-Lonebear D, Barceló NE, Akee R, Carroll SR. American Indian Reservations and COVID-19: Correlates of Early Infection Rates in the Pandemic. J Public Health Manag Pract. 2020;26(4):371–7. pmid:32433389
- 22.
National Center for Health Statistics. CDC Wonder, Underlying Cause of Death 2018-2023. https://wonder.cdc.gov/deaths-by-underlying-cause.html
- 23.
Division of Vital Statistics DV. 2003-2022 Restricted-Use Detailed Mortality - All Counties Files. Hyattsville, MD: National Center for Health Statistics. 2022.
- 24.
US Census Bureau. Single-race Population Estimates, United States, 2010-2022. 2023. https://wonder.cdc.gov/wonder/help/single-race.html#About%202020-2022
- 25.
Revision of profile: Hispanic/Latino Americans. https://minorityhealth.hhs.gov/node/10/revisions/524/view 2023. 2025 May 11.
- 26. Morales LS, Lara M, Kington RS, Valdez RO, Escarce JJ. Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved. 2002;13(4):477–503. pmid:12407964
- 27.
Centers for Disease and Prevention, National Center for Health Statistics. Instruction Manual ICD-10 Cause-of-Death Lists for Tabulating Mortality Statistics. 2009.
- 28.
Centers for Disease Control and Prevention. Alcohol Related Disease Impact (ARDI) Application Website. www.cdc.gov/ARDI. 2024.
- 29.
Preston SH, Heuveline P, Guillot M. Demography: measuring and modeling population processes. Malden, MA: Blackwell Publishers. 2001.
- 30. Auger N, Feuillet P, Martel S, Lo E, Barry AD, Harper S. Mortality inequality in populations with equal life expectancy: Arriaga’s decomposition method in SAS, Stata, and Excel. Ann Epidemiol. 2014;24(8):575–80, 580.e1. pmid:24970490
- 31. Naimi TS, Sherk A, Lawrence KW, Reece J, Esser MB. Racial and Ethnic Disparities in Alcohol Consumption and Mortality in the U.S. Am J Prev Med. 2025;69(6):107968. pmid:40957228
- 32. Knott C, Bell S, Britton A. Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies. Diabetes Care. 2015;38(9):1804–12. pmid:26294775
- 33. Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12:182. pmid:25567363
- 34.
Diagnostic and Statistical Manual of Mental Disorders. DSM Library. https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596 2024 December 30.
- 35. Molina PE, Gardner JD, Souza-Smith FM, Whitaker AM. Alcohol abuse: critical pathophysiological processes and contribution to disease burden. Physiology (Bethesda). 2014;29(3):203–15. pmid:24789985
- 36. Czeisler MÉ, Lane RI, Wiley JF, Czeisler CA, Howard ME, Rajaratnam SMW. Follow-up survey of US adult reports of mental health, substance use, and suicidal ideation during the COVID-19 pandemic, September 2020. JAMA Netw Open. 2021;4:e2037665.
- 37. Laing R, Donnelly CA. Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality. PLoS One. 2024;19(7):e0306395. pmid:38980856
- 38. Haskins C, Noonan C, MacLehose R, Buchwald D, Manson SM. COVID-19 pandemic effects on emotional health and substance use among urban American Indian and Alaska Native people. J Psychosom Res. 2023;172:111424. pmid:37385054
- 39. Guenzel N, Struwe L. Historical Trauma, Ethnic Experience, and Mental Health in a Sample of Urban American Indians. J Am Psychiatr Nurses Assoc. 2020;26(2):145–56. pmid:31747831
- 40. Masotti P, Dennem J, Bañuelos K, Seneca C, Valerio-Leonce G, Inong CT, et al. The Culture is Prevention Project: measuring cultural connectedness and providing evidence that culture is a social determinant of health for Native Americans. BMC Public Health. 2023;23(1):741. pmid:37085784
- 41.
US Commission on Civil Rights. Broken promises: Continuing federal funding shortfall for Native Americans. US Commission on Civil Rights. 2018.
- 42. Yellow Horse AJ, Yang TC, Huyser KR. Structural inequalities established the architecture for COVID-19 pandemic among Native Americans in Arizona: a geographically weighted regression perspective. J Racial and Ethnic Health Disparities. 2022;9:165–75.
- 43. Jernigan VBB, Huyser KR, Valdes J, Simonds VW. Food Insecurity among American Indians and Alaska Natives: A National Profile using the Current Population Survey-Food Security Supplement. J Hunger Environ Nutr. 2017;12(1):1–10. pmid:28491205
- 44. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511–8. pmid:2232018
- 45. Spillane NS, Schick MR, Kirk-Provencher KT, Nalven T, Goldstein SC, Crawford MC, et al. Trauma and Substance Use among Indigenous Peoples of the United States and Canada: A Scoping Review. Trauma Violence Abuse. 2023;24(5):3297–312. pmid:36197078
- 46. Wu L-T, Woody GE, Yang C, Pan J-J, Blazer DG. Racial/ethnic variations in substance-related disorders among adolescents in the United States. Arch Gen Psychiatry. 2011;68(11):1176–85. pmid:22065533
- 47. Walls M, Sittner KJ, Whitbeck LB, Herman K, Gonzalez M, Elm JHL, et al. Prevalence of Mental Disorders from Adolescence through Early Adulthood in American Indian and First Nations Communities. Int J Ment Health Addict. 2020;19(6):2116–30. pmid:35002580
- 48. Crump C, Sundquist K, Winkleby MA, Sundquist J. Mental disorders and risk of accidental death. Br J Psychiatry. 2013;203(3):297–302. pmid:23969485
- 49. Gau SSF, Cheng ATA. Mental illness and accidental death. Case-control psychological autopsy study. Br J Psychiatry. 2004;185:422–8. pmid:15516552
- 50. Gone JP. Community Mental Health Services for American Indians and Alaska Natives: Reconciling Evidence-Based Practice and Alter-Native Psy-ence. Annu Rev Clin Psychol. 2023;19:23–49. pmid:36623913
- 51. Espey DK, Jim MA, Cobb N, Bartholomew M, Becker T, Haverkamp D. Leading causes of death and all-cause mortality in American Indians and Alaska Natives. Am J Public Health. 2014;104:S303–11.
- 52.
Arias E, Schauman WS, Eschbach K, Sorlie PD, Backlund E. The Validity of race and Hispanic origin reporting on death certificates in the United States. Washington, DC: National Center for Health Statistics; 2008. https://stacks.cdc.gov/view/cdc/7066